Updated: May 19, 2026

David A Santos

RIGLRIGEL PHARMACEUTICALS INCSEC CIK: 0001820066
Estimated Net Worth
$2.21 Million15.5%vs Last Year
Last Updated: May 19, 2026 11:49 PM EST

Transaction Summary

Total Transactions18
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions3

Transaction Volume

Total Volume-$109.28K
Net Volume$109.28K
Buy Volume$0.00
Sell Volume-$109.28K

Trade Analysis

AVG Trade Size-$24.33K
Largest Trade$0.00
Most Active MonthFeb
Most Active Year2025

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

David A Santos has an estimated net worth of $2.21 Million. This is based on reported shares in RIGEL PHARMACEUTICALS INC.



2024 was David A Santos's most active year for acquiring shares with 5 total transactions. David A Santos's most active month to acquire stocks was the month of December. 2024 was David A Santos's most active year for disposing of shares, totalling 2 transactions. David A Santos's most active month to dispose stocks was the month of January. 2020 saw David A Santos paying a total of $0.00 for 250,000 shares, this is the most they've acquired in one year. In 2026 David A Santos cashed out on 9,264 shares for a total of $328,667.70, their largest year based on trade value.

Holdings & Transactions

RIGLrigel pharmaceuticals inc
EVP, Chief Commercial Officer
Updated: Feb 19, 2026VIEW QUOTE
Form TypeSEC Filing
0.4519.43K62.87KFeb 17View
-0.083.55K$34.62-$122.76K43.44KFeb 10View
-0.115.72K$36.01-$205.91K46.99KFeb 02View
7.39K7.39KSep 15View
14.72K14.73KMar 17View
-0.073.92K$21.38-$83.84K51.70KFeb 04 - 05View
0.9634.51K70.41KJan 29View
8.00K8.00KNov 25View
158.50K158.50KFeb 28View
-0.0414.52K$1.14-$16.50K349.09KFeb 02 - 05View
2.37366.00K520.61KJan 23View
-0.045.39K$1.66-$8.95K144.61KFeb 02View
2.42290.00K410.00KJan 26View
50.00K50.00KDec 28View
15.00150.00K160.00KJan 24View
137.50K137.50KJan 27View
250.00K250.00KAug 19View
View